Growth velocity during the first postnatal week of life is linked to a spurt of IGF-I effect.

There is adequate evidence that growth during the perinatal period is linked to the risk of several adult onset diseases, and recent findings indicate that the insulin-like growth factor (IGF) system is involved in prenatal growth, as reflected in birthweight. However, whether major components of the IGF system are involved in the immediate post-natal growth has not been studied. Maternal questionnaires were completed, and laboratory measurements of several variables, including IGF-I, IGF-II and IGF-binding protein-3 (IGFBP-3), were made for a total of 331 apparently healthy full-term newborns, from whom routine blood samples were taken during the first 5 days of their life. Birthweight and weight at the time of bleeding were among the recorded variables, and the difference divided by the age in days of the newborn was considered as reflecting immediate postnatal growth velocity. Immediate postnatal growth velocity was strongly positively associated with IGF-I. The squared adjusted correlation coefficient was 0.29 when IGF-I was incorporated in the model predicting postnatal growth velocity but was only 0.08 when IGF-I was excluded. In contrast, IGF-II and IGFBP-3 had no effect on postnatal growth velocity. It thus appears that IGF-I underlies growth during the immediate postnatal period. To the extent that perinatal growth may affect adult onset diseases, the findings of this study suggest that the action of IGF-I during the immediate postnatal period may represent a process of major importance.

[1]  D. Trichopoulos,et al.  Birth Size and Neonatal Levels of Major Components of the IGF System: Implications for Later Risk of Cancer , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[2]  M. Stampfer,et al.  Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. , 2001, Journal of the National Cancer Institute.

[3]  L. Giudice,et al.  Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. , 2001, The Journal of clinical endocrinology and metabolism.

[4]  J. Eriksson,et al.  Early growth and coronary heart disease in later life: longitudinal study , 2001, BMJ : British Medical Journal.

[5]  C. Mantzoros,et al.  Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. , 2001, The Journal of clinical endocrinology and metabolism.

[6]  R. Huxley,et al.  The role of size at birth and postnatal catch‐up growth in determining systolic blood pressure: a systematic review of the literature , 2000, Journal of hypertension.

[7]  H. Adami,et al.  Risk of breast cancer in prematurely born women. , 2000, Journal of the National Cancer Institute.

[8]  M. Rudnicki,et al.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells. , 2000, Developmental biology.

[9]  L. Baur,et al.  Effects of Gender, Body Composition and Birth Size on IGF-I in 7- and 8-Year-Old Children , 1999, Hormone Research in Paediatrics.

[10]  P. Ryan,et al.  The relationship between birth weight and blood pressure amplifies from childhood to adulthood. , 1999, Journal of hypertension.

[11]  G. van Zant,et al.  Recent progress in identifying genes regulating hematopoietic stem cell function and fate. , 1998, Current opinion in cell biology.

[12]  L. Signorello,et al.  Perinatal determinants of adult cardiovascular disease and cancer , 1998, Scandinavian journal of social medicine.

[13]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[14]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[15]  W. Rascher,et al.  IGF‐I, IGF‐II, free IGF‐I and IGFBP‐1, ‐2 and ‐3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns , 1997, Acta paediatrica.

[16]  R. Winston,et al.  Expression of mRNA for the insulin‐like growth factors and their receptors in human preimplantation embryos , 1997, Molecular reproduction and development.

[17]  M. Kogevinas,et al.  The risk profile of childhood leukaemia in Greece: a nationwide case-control study. , 1997, British Journal of Cancer.

[18]  J. Robins,et al.  Birthweight as a risk factor for breast cancer , 1996, The Lancet.

[19]  J. Pezzullo,et al.  Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at term. , 1996, Early human development.

[20]  J. Spencer,et al.  Third trimester fetal growth and umbilical venous blood concentrations of IGF-1, IGFBP-1, and growth hormone at term. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[21]  H. Adami,et al.  Prenatal and neonatal risk factors for childhood lymphatic leukemia. , 1995, Journal of the National Cancer Institute.

[22]  J. Suttie,et al.  Effects of insulin-like growth factor-I (IGF-I) and IGF-II on the growth of antler cells in vitro. , 1994, The Journal of endocrinology.

[23]  Z. Hochberg,et al.  Insulin-like growth factor I accelerates proliferation and differentiation of cartilage progenitor cells in cultures of neonatal mandibular condyles. , 1993, Acta Endocrinologica.

[24]  H. Adami,et al.  Maternal and perinatal risk factors for childhood leukemia. , 1991, Cancer research.

[25]  R N Hoover,et al.  Prenatal and perinatal risk factors for testicular cancer. , 1986, Cancer research.